3 ms·
Sure, but that's missing the point. Researchers need to study therapy sessions compared to therapy sessions with psychedelics. If they have enough people, incl
by PragmaticPulp 6y ago
Sure, but that's missing the point.
Researchers need to study therapy sessions compared to therapy sessions with psychedelics. If they have enough people, include a third arm with traditional antidepressant medication.
It's not blinded, but at least we would have data to compare to existing treatments. Double-blind isn't the only way to run a trial.
- colechristensen 6y agoI wouldn't think it's missing the point, you have a different topic there. And the A/B comparison doesn't have much room for common ground to control for. Perhaps not a single study comparing both, but separate studies (many) of different treatment methods and replications of those treatment methods and then meta-analysis studies on the whole lot. (and much of this already exists)